Screening and Diagnosis for Pancreatic Cancer.
- Author:
Jong Kyun LEE
1
Author Information
1. Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. leejk@skku.edu
- Publication Type:Review ; English Abstract
- Keywords:
Pancreatic cancer;
Screening;
Diagnosis
- MeSH:
Cholangiopancreatography, Endoscopic Retrograde;
Humans;
Laparoscopy;
Magnetic Resonance Imaging;
Pancreatic Neoplasms/*diagnosis;
Tomography, X-Ray Computed;
Tumor Markers, Biological
- From:The Korean Journal of Gastroenterology
2008;51(2):84-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pancreatic cancer has an extremely poor prognosis mainly because the diagnosis is made late. Therefore, screening and early diagnosis are essential ways to improve the patient's survival. There is no cost-effective screening method in general population because pancreatic cancer is relatively uncommon. Some patients belonging to high-risk groups such as hereditary pancreatic cancer, familial pancreatic caner kindred, new-onset diabetes in eldery patients, can be targets of secondary screening. To date, multi-detector CT is the standard method for proper diagnosis of pancreatic cancer. EUS play roles for identifying small lesion and cytologic examination. Other modalities like endoscopic retrograde cholangiopancreatography (ERCP), MRI/MRCP, positron emission tomography (PET), or laparoscopy, can be used selectively for the diagnosis and assessment of resectability
